| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 1,471 | $216.54 | $318,530.34 | -12.9% | -19.1% | -7.6% | |
| Aug 10, 2023 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 700 | $216.52 | $151,564.00 | -2.7% | -19.1% | -7.6% | |
| Aug 10, 2023 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 3,577 | $1.33 | $4,748.89 | -1.3% | +2.3% | +22.3% | |
| Aug 10, 2023 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 1,573 | $1.33 | $2,088.38 | -0.8% | +2.3% | +22.3% | |
| Aug 10, 2023 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 1,699 | $1.33 | $2,255.65 | -1.8% | +2.3% | +22.3% | |
| Aug 10, 2023 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 559 | $1.33 | $742.19 | -4.4% | +2.3% | +22.3% | |
| Aug 10, 2023 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 13,782 | $1.33 | $18,297.23 | -2.1% | +2.3% | +22.3% | |
| Aug 9, 2023 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.82 | $181,751.79 | - | -24.3% | -19.2% | |
| Aug 9, 2023 | WST West Pharmaceutical Services Inc | Witherspoon Charles63 | VP &Treasurer | Sell | 1,680 | $396.54 | $666,187.20 | -47.9% | -17.4% | -26.7% | |
| Aug 8, 2023 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President &CEO | Sell | 44,000 | $394.77 | $17,369,820.23 | -3.0% | -16.7% | -26.4% | |
| Aug 8, 2023 | WST West Pharmaceutical Services Inc | Abraham Silji62 | SVP, Chief Technology Officer | Sell | 8,160 | $397.18 | $3,240,972.29 | -49.2% | -16.7% | -26.4% | |
| Aug 8, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 11,600 | $551.75 | $6,400,329.95 | -0.6% | -18.1% | +5.7% | |
| Aug 7, 2023 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 650,000 | $1.84 | $1,194,998.09 | - | -26.4% | -26.4% | |
| Aug 7, 2023 | EXAS Exact Sciences Corp | Baranick Brian75 | Gen. Mgr., Precision Oncology | Sell | 1,350 | $85.04 | $114,804.00 | -13.2% | -23.4% | -34.2% | |
| Aug 4, 2023 | WAT Waters Corp /de/ | Kuebler Christopher A58 | Director | Sell | 4,000 | $291.48 | $1,165,920.00 | -21.8% | -15.3% | +19.2% | |
| Aug 4, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $549.67 | $10,993,366.55 | -1.0% | -18.4% | +12.2% | |
| Aug 3, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 600 | $20.10 | $12,060.00 | -0.2% | -16.4% | +18.7% | |
| Aug 2, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,819 | $11.35 | $31,987.84 | -0.3% | -52.0% | +109.4% | |
| Aug 2, 2023 | WST West Pharmaceutical Services Inc | Birkett Bernard | Sr VP, Chief Fin &Ops Off | Sell | 22,334 | $370.39 | $8,272,215.84 | -71.4% | -14.1% | -18.3% | |
| Aug 2, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,000 | $44.21 | $265,265.10 | -1.1% | -10.2% | +134.5% | |
| Aug 1, 2023 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 29,100 | $553.82 | $16,116,300.00 | -34.7% | -20.5% | +12.4% | |
| Jul 31, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 485 | $2.26 | $1,096.10 | -0.4% | -59.8% | +32.2% | |
| Jul 31, 2023 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 662 | $2.26 | $1,496.12 | -0.3% | -59.8% | +32.2% | |
| Jul 31, 2023 | MEDP Medpace Holdings, Inc. | Brady Kevin M.45 | CFO &Treasurer | Sell | 7,000 | $255.00 | $1,785,000.00 | -53.8% | -4.5% | +49.4% | |
| Jul 28, 2023 | DHR Danaher Corp /de/ | Raskas Daniel67 | SVP - Corporate Development | Sell | 11,213 | $260.65 | $2,922,651.63 | -22.7% | -25.5% | +5.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.